Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
| ▸ | LCK | P06239 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CTH | P32929 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27224865 | 0.97 | PIK3CD (0.34) | PIK3CDLCKMEN1KMT2ACTH | |
| SCHEMBL12131662 | 0.91 | LCK (0.34) | PIK3CDLCKMEN1KMT2A | |
| SCHEMBL27579643 | 0.89 | LCK (0.34) | PIK3CDLCK | |
| SCHEMBL7369255 | 0.87 | MEN1 (0.34) | PIK3CDMEN1KMT2A | |
| SCHEMBL15739629 | 0.85 | BLM (0.35) | LCKCA2 | |
| SCHEMBL1292539 | 0.85 | PIK3CD (0.43) | PIK3CDMEN1KMT2ACTHCA2 | |
| SCHEMBL6417812 | 0.84 | CHRM2 (0.33) | PIK3CDLCKMEN1KMT2A | |
| SCHEMBL8306690 | 0.84 | LCK (0.41) | LCK | |
| SCHEMBL11793063 | 0.82 | PIK3CD (0.42) | PIK3CDMEN1KMT2ACTHCA2 | |
| SCHEMBL15745725 | 0.82 | PIK3CD (0.42) | PIK3CDMEN1KMT2ACTHCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129021-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2025-04-24 | — | — | US | disclosed |
| WO-2025064718-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2025-03-27 | — | — | WO | disclosed |
| US-20240109917-A1 | PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS | ACTELION PHARMACEUTICALS LTD (CH) | 2024-04-04 | — | — | US | disclosed |
| EP-4267585-A1 | PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS | Actelion Pharmaceuticals Ltd (CH) | 2023-11-01 | — | — | EP | disclosed |
| WO-2023071601-A1 | DESLORATADINE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 天津市昕晨投资发展有限公司 | 2023-05-04 | — | — | WO | disclosed |
| WO-2022136509-A1 | PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS | ACTELION PHARMACEUTICALS LTD (CH) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022136509-A1 | PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS | ACTELION PHARMACEUTICALS LTD (CH) | 2022-06-30 | — | — | WO | disclosed |
| US-10364245-B2 | Kinase inhibitors | CHIESI FARMACEUTICI S.P.A. (IT) | 2019-07-30 | — | — | US | disclosed |
| US-20180354945-A1 | KINASE INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2018-12-13 | — | — | US | disclosed |
| US-20110243892-A1 | Y-SHAPE BRANCHED HYDROPHILIC POLYMER DERIVATIVES, THEIR PREPARATION METHODS, CONJUGATES OF THE DERIVATIVES AND DRUG MOLECULES, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE CONJUGATES | JI SHISHAN | 2011-10-06 | — | — | US | disclosed |
| US-8003089-B2 | such as triethanolamine with 2 hydroxyethyl groups derivatized with polyethylene glycol, and the amine group conjugated to drugs such as antitumor agent interferon | BEIJING JIANKAI TECHNOLOGY CO., LTD. (CN) | 2011-08-23 | — | — | US | disclosed |
| EP-0790986-B1 | ANILINE DERIVATIVES | ZENECA LTD (GB) | 1999-01-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180354945-A1 | KINASE INHIBITORS | MAPK1, MAP3K1, MAP3K6 | PIK3CD 773/4885LCK 471/4885MEN1 4752/4885 |
| US-10364245-B2 | Kinase inhibitors | MAPK1, MAP3K1, MAP3K6 | PIK3CD 773/4885LCK 471/4885MEN1 4752/4885 |
| US-20250129021-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | MYC, KRAS, NRAS | PIK3CD 516/4885LCK 1456/4885MEN1 798/4885 |
| US-20110243892-A1 | Y-SHAPE BRANCHED HYDROPHILIC POLYMER DERIVATIVES, THEIR PREPARATION METHODS, CONJUGATES OF THE DERIVATIVES AND DRUG MOLECULES, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE CONJUGATES | EGFR, NPY5R, NPY4R | PIK3CD 501/4885LCK 358/4885MEN1 2396/4885 |
| US-20240109917-A1 | PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS | PDGFRA, PDGFRB, ABL1 | PIK3CD 92/4885LCK 120/4885MEN1 3001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.